Kanamycin – Injection Products
Exceptions or additions to the recognized standards
Minimum Inhibitory | Disk Diffusion | |||||
|---|---|---|---|---|---|---|
| Pathogen | S | I | R | S | I | R |
| Staphylococcus aureus | ≤ 16 | 32 | ≥ 64 | ≥ 18 | 14-17 | ≤ 13 |
S = Susceptible; I = Intermediate; R = Resistant
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.